A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies

Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types

Jens M. Kelm, Nicholas Timmins, Catherine J. Brown et al. · Biotechnology and Bioengineering · 2003 · 916 citations

Life Sciences, Bioengineering, Cell Biology +13

COMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIES

Stefan Wilkening, Frank Stahl, Augustinus Bader · Drug Metabolism and Disposition · 2003 · 771 citations

Pharmacy, Molecular Biology, Toxicology +17

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions

Karin Fattinger · Clinical Pharmacology & Therapeutics · 2001 · 505 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury

Jinghai J. Xu, Peter Henstock, Margaret C. Dunn et al. · Toxicological Sciences · 2008 · 492 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver

Stephan R. Vavricka, Jessica van Montfoort, Huy Riêm Ha et al. · Hepatology · 2002 · 372 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17